Here are four notes:
1. The transaction was valued at $90,207.
2. Mr. Phillips sold the shares at an average price of $23.10 per share.
3. He currently owns 11,557 Exactech shares.
4. On April 13, Robert W. Baird upgraded Exactech shares to an “outperform” rating.
More articles on devices:
4 trends in outpatient spine surgery from Amendia
InVivo Therapeutics adds Penn Medicine as INSPIRE study site: 4 points
DJO Global reports Q1 12.7% net sales growth, $38.3M net loss: 7 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
